Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03598608
Brief Title: Study to Evaluate the Safety and Efficacy of a Combination of MK-4280 and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003)

First Submitted : July 16, 2018
First Submitted that Met QC Criteria : July 16, 2018
First Posted : July 25, 2018 (Estimate)

Last Update Submitted that Met QC Criteria : August 20, 2019
Last Update Posted : August 21, 2019